Success Metrics

Active Trials
3(75%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Recruiting2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

not_yet_recruiting125%
active_not_recruiting125%
recruiting250%

Recent Activity

3 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Advanced MRI in IVH

NCT07412886
active_not_recruiting

Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI

NCT03297125
recruitingnot_applicable

Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

NCT06113705
recruitingnot_applicable

Epileptogenic Network Visualisation With Advanced MRI

NCT06059157

Clinical Trials (4)

Showing 4 of 4 trials
NCT07412886Not Applicable

Advanced MRI in IVH

Not Yet Recruiting
NCT03297125

Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI

Active Not Recruiting
NCT06113705Not Applicable

Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

Recruiting
NCT06059157Not Applicable

Epileptogenic Network Visualisation With Advanced MRI

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4